{"id":"W1984714210","doi":"10.1097/qad.0000000000000131","title":"Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1","year":2013,"lang":"en","type":"article","venue":"AIDS","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Maraviroc; Efavirenz; CCR5 receptor antagonist; Zidovudine; Lamivudine; Medicine; Viral load; Internal medicine; Adverse effect; Pharmacology; Gastroenterology; Virology; Human immunodeficiency virus (HIV); Viral disease; Receptor; Antiretroviral therapy; Chemokine receptor; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002362686,0.000480997,0.001252119,0.0002510412,0.0002780344,0.000666446,0.0003464729,0.0008284189,0.00215829],"category_scores_gemma":[0.003207155,0.0002617952,0.001167095,0.0001939108,0.0004332202,0.0006055252,0.0002066225,0.001534192,0.0002718872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004434496,"about_ca_system_score_gemma":0.0005016228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003147883,"about_ca_topic_score_gemma":0.0007215023,"domain_scores_codex":[0.9986538,0.0009633605,0.00008199594,0.0001013618,0.0001053944,0.00009404423],"domain_scores_gemma":[0.9983196,0.0008161227,0.0003437968,0.00007598479,0.00007011618,0.0003743408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8942654,0.006861141,0.006864686,0.000453203,0.0009184948,0.00007162921,0.0001488739,0.0006017722,0.005927345,0.0001226632,0.0006639511,0.08310094],"study_design_scores_gemma":[0.3965663,0.5410702,0.0527724,0.0001334736,0.001386867,0.0002671849,0.0001103212,0.002138793,0.002805391,0.0003224654,0.002383365,0.0000433694],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993239,0.004735923,0.0001504452,0.0003512702,0.000123775,0.0002414106,0.0002054252,0.00002863563,0.0009240684],"genre_scores_gemma":[0.9981395,0.0007344777,0.0002628628,0.000220023,0.0001318013,0.0001267109,0.0001422452,0.000003284438,0.0002390617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002362686,"threshold_uncertainty_score":0.01249522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006457593049599562,"score_gpt":0.2230402490531327,"score_spread":0.2165826560035332,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}